Cellect(QNRX) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Quoin Pharmaceuticals Announces Second Quarter 2025 Financial Results and Corporate Update ASHBURN, Va., August 7, 2025 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) ("Quoin" or the "Company"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases provided a corporate update today on its clinical progress and advocacy initiatives and announced its financial results for the second quarter ended June 30, 2025. "Second quarter of 2025 was one of ...